The research on the early warning value and intervention effect of the mobile and remote monitoring function of the implanted device on the common cardiovascular events in the elderly.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017222

Enrollment

Unknown

Registered

2018-07-18

Start date

2018-07-21

Completion date

Unknown

Last updated

2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular and cerebrovascular diseases

Interventions

LINQ implaned group:Mobile data analysis in the device

Routine treatment group:Regular review of ECG /Holter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged=60 years; 2. Repeated(=2)unexplained syncope; 3. Meet the Cardiac implantation monitor implantation indications, 2016 ESC atrial fibrillation management guide, and consensus of Chinese experts on diagnosis and treatment of syncope in 2014 published by 2009 European heart association ESC, including the patients with repeated(=2)unexplained syncope or Unexplained palpitations, and the Specific indications for implantation include that: the patients with Type I recurrent unexplained syncope, but without various high-risk ECG abnormalities requiring emergency hospitalization or intensive assessment, and the syncope are expected to recur during the battery life of the implantation monitor; the patients with Type I recurrent unexplained syncope, requiring emergency hospitalization or intensive assessment, but the cause and proper treatment of syncope have not been determined; the patients with Type I1a severe but not frequent palpitations, but the use of ECG and other ECG monitoring methods has not been able to determine the cause; the patients with Type I1a unexplained syncope, occurring momentary loss of consciousness, but without the arrhythmia; 4. Voluntary participation and signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. The patients with mental illness, and can not cooperate well with follow-up and related examination; 2. A pacemaker has been implanted; 3. non-voluntary participation and without signing of informed consent.

Design outcomes

Primary

Measure	Time frame
Detection rate of cardiac arrhythmias associated with syncope/palpitations;Time of discovery of cardiac arrhythmias associated with syncope/palpitations;Detection rate of atrial fibrillation;Finding time for atrial fibrillation;	—

Countries

China

Contacts

Public ContactTong Zou

Beijing Hospital, National Center of Gerontology

1587424738@qq.com+86 18649345136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026